WHO Drug Pricing Talks May Fail to End Secrecy, Activists Fear

GENEVA (Reuters)—Governments are working on a drug pricing transparency deal at the World Health Organization's (WHO) annual assembly, but activists said on Thursday they fear crucial costs may be left out, enabling pharmaceutical firms to keep prices high. Campaigners say some drugs are exhorbitantly priced, even though they are often developed with public funding, and... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Drug Updates Pharma Co. News drug pricing transparency drug pricing transparency deal pharmaceutical industry World Health Organization (WHO) Source Type: research